NOTV Insider Trading
Inotiv, Inc. | Services-Commercial Physical & Biological Research
Comprehensive Trading Performance Summary
The investment history of corporate insiders at Inotiv, Inc. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Services-Commercial Physical & Biological Research sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-20 00:41 | 2026-02-17 | Taylor Beth A. | Officer - Chief Financial Officer | SELL | $0.29 | 2,888 | $846 | 145,480 | -1.9% |
| 2026-02-20 00:40 | 2026-02-17 | Sagartz John E | Officer - Chief Strategy Officer | SELL | $0.29 | 2,119 | $616 | 735,697 | -0.3% |
| 2026-02-20 00:39 | 2026-02-17 | Leasure Robert Jr. | Director, Officer - President and CEO | SELL | $0.30 | 16,810 | $4,964 | 1,256,215 | -1.3% |
| 2026-02-04 00:14 | 2026-02-02 | Leasure Robert Jr. | Director, Officer - President and CEO | SELL | $0.50 | 113,297 | $57,034 | 1,273,025 | -8.2% |
| 2025-12-03 00:41 | 2025-12-01 | Neff R Matthew | Director | SELL | $0.89 | 2,000 | $1,771 | 151,102 | -1.3% |
| 2025-11-05 01:16 | 2025-11-03 | Neff R Matthew | Director | SELL | $1.24 | 2,000 | $2,487 | 153,102 | -1.3% |
| 2025-10-03 23:25 | 2025-10-01 | Neff R Matthew | Director | SELL | $1.43 | 2,000 | $2,858 | 145,102 | -1.4% |
| 2025-09-04 17:46 | 2025-09-02 | Neff R Matthew | Director | SELL | $1.67 | 2,000 | $3,338 | 147,102 | -1.3% |
| 2025-08-04 23:28 | 2025-08-01 | Neff R Matthew | Director | SELL | $1.91 | 2,000 | $3,818 | 149,102 | -1.3% |
| 2025-07-03 23:30 | 2025-07-01 | Neff R Matthew | Director | SELL | $1.81 | 2,000 | $3,621 | 151,102 | -1.3% |
| 2025-06-04 23:05 | 2025-06-02 | Neff R Matthew | Director | SELL | $2.62 | 2,000 | $5,246 | 153,102 | -1.3% |
| 2025-04-02 23:32 | 2025-04-01 | Coelho Mary Theresa | Director | SELL | $2.35 | 5,500 | $12,916 | 74,303 | -6.9% |
| 2025-02-21 00:34 | 2025-02-18 | Freeman Jeffrey Brennan | Officer - VP-Finance & Corp. Controller | SELL | $4.05 | 1,339 | $5,416 | 27,478 | -4.6% |
| 2025-02-21 00:33 | 2025-02-18 | Taylor Beth | Officer - Chief Financial Officer | SELL | $4.01 | 4,370 | $17,507 | 108,368 | -3.9% |
| 2025-02-21 00:33 | 2025-02-18 | Sagartz John E | Director, Officer - Chief Strategy Officer | SELL | $3.94 | 2,113 | $8,316 | 707,816 | -0.3% |
| 2025-02-21 00:32 | 2025-02-18 | Leasure Robert Jr. | Director, Officer - President and CEO | SELL | $3.82 | 73,617 | $281,136 | 956,592 | -7.1% |
| 2025-02-05 00:15 | 2025-01-31 | Leasure Robert Jr. | Director, Officer - President and CEO | SELL | $4.15 | 22,700 | $94,298 | 1,030,209 | -2.2% |
| 2025-02-05 00:14 | 2025-01-31 | Taylor Beth | Officer - Chief Financial Officer | SELL | $4.47 | 2,054 | $9,171 | 112,738 | -1.8% |
| 2025-02-05 00:13 | 2025-01-31 | Sagartz John E | Director, Officer - Chief Strategy Officer | SELL | $4.48 | 2,118 | $9,479 | 709,929 | -0.3% |
| 2025-02-05 00:12 | 2025-01-31 | Krupp Jeffrey Arthur | Officer - Chief Human Resources Officer | SELL | $4.42 | 2,508 | $11,096 | 28,557 | -8.1% |
| 2024-12-24 05:47 | 2024-12-19 | Landman David | Director | BUY | $4.25 | 23,529 | $99,998 | 176,851 | +15.3% |
| 2024-12-13 02:46 | 2024-12-10 | Beattie John Gregory | Officer - Chief Operating Officer | BUY | $4.75 | 30,000 | $142,500 | 161,761 | +22.8% |
| 2024-12-11 00:13 | 2024-12-10 | Brown Nigel | Director | BUY | $4.26 | 7,500 | $31,950 | 65,537 | +12.9% |
| 2024-12-10 16:34 | 2024-12-06 | Harrington Michael J | Director | BUY | $3.98 | 10,000 | $39,822 | 37,500 | +36.4% |
| 2024-12-10 16:31 | 2024-12-06 | Landman David | Director | BUY | $4.14 | 100,000 | $414,000 | 153,322 | +187.5% |
| 2024-01-26 00:19 | 2019-06-07 | Leasure Robert Jr. | Director, Officer - President and CEO | BUY | $1.98 | 7,500 | $14,864 | 105,000 | +7.7% |
| 2023-12-16 01:33 | 2023-12-14 | Garrett Michael | Officer - Chief Commercial Officer | BUY | $2.83 | 5,000 | $14,145 | 16,467 | +43.6% |
| 2023-12-16 01:33 | 2023-12-14 | Beattie John Gregory | Officer - Chief Operating Officer | BUY | $3.12 | 47,966 | $149,836 | 111,761 | +75.2% |
| 2023-03-16 23:03 | 2023-03-14 | Sagartz John E | Director, Officer - Chief Strategy Officer | BUY | $4.91 | 5,100 | $25,041 | 692,047 | +0.7% |
| 2023-02-25 00:02 | 2023-02-22 | Beattie John Gregory | Officer - Chief Operating Officer | BUY | $6.99 | 5,000 | $34,950 | 63,795 | +8.5% |
| 2022-12-29 15:12 | 2022-12-09 | Pitchford William D | Officer - Chief Human Resources Officer | SELL | $5.82 | 2,123 | $12,366 | 74,051 | -2.8% |
| 2022-12-03 04:11 | 2022-12-01 | Neff R Matthew | Director | SELL | $6.12 | 1,000 | $6,120 | 62,388 | -1.6% |
| 2022-11-03 23:13 | 2022-11-01 | Neff R Matthew | Director | SELL | $21.12 | 1,000 | $21,123 | 63,388 | -1.6% |
| 2022-10-19 00:37 | 2022-10-17 | Neff R Matthew | Director | SELL | $19.10 | 1,000 | $19,100 | 64,388 | -1.5% |
| 2022-09-19 23:06 | 2022-09-15 | Garrett Michael | Officer - Chief Commercial Officer | BUY | $23.06 | 1,000 | $23,058 | 2,000 | +100.0% |
| 2022-09-13 23:04 | 2022-09-09 | Beattie John Gregory | Officer - Chief Operating Officer | BUY | $22.34 | 8,900 | $198,826 | 51,694 | +20.8% |
| 2022-03-16 17:47 | 2022-03-15 | Harkness James | Officer - Chief Operating Officer, RMS | BUY | $19.65 | 38,968 | $765,635 | 38,968 | +100.0% |
| 2022-02-24 01:22 | 2022-02-22 | Downing Philip A | Officer - Sr. VP, Preclinical Srvcs. | BUY | $23.97 | 2,000 | $47,946 | 42,195 | +5.0% |
| 2022-02-22 15:54 | 2022-02-18 | Taylor Beth | Officer - VP- Finance & CFO | BUY | $23.07 | 5,000 | $115,358 | 83,875 | +6.3% |
| 2022-02-22 15:53 | 2022-02-17 | Davis Gregory Cole | Director | BUY | $22.39 | 5,000 | $111,928 | 37,683 | +15.3% |
| 2022-02-22 15:52 | 2022-02-18 | Garrett Michael | Officer - Chief Commercial Officer | BUY | $23.50 | 1,000 | $23,500 | 1,000 | +100.0% |
| 2022-02-19 01:49 | 2022-02-18 | Pitchford William D | Officer - Chief HR Officer | BUY | $21.12 | 3,500 | $73,920 | 76,174 | +4.8% |
| 2022-02-19 01:48 | 2022-02-16 | Beattie John Gregory | Officer - Chief Operating Officer | BUY | $22.71 | 11,400 | $258,871 | 42,794 | +36.3% |
| 2022-02-18 05:42 | 2022-02-17 | Leasure Robert Jr. | Director, Officer - President and CEO | BUY | $23.03 | 5,000 | $115,131 | 285,216 | +1.8% |
| 2022-02-18 01:18 | 2022-02-17 | Sagartz John E | Director, Officer - Chief Strategy Officer | BUY | $19.95 | 2,506 | $49,999 | 681,030 | +0.4% |
| 2021-12-31 04:40 | 2021-12-22 | Downing Philip A | Officer - Sr. VP, Preclinical Srvcs. | SELL | $43.04 | 3,057 | $131,577 | 40,195 | -7.1% |
| 2021-06-08 23:10 | 2021-06-07 | Sagartz John E | Director, Officer - Chief Strategy Officer | BUY | $28.70 | 1,742 | $49,995 | 648,524 | +0.3% |
| 2021-06-01 23:01 | 2021-05-27 | Sagartz John E | Director, Officer - Chief Strategy Officer | BUY | $24.78 | 2,017 | $49,977 | 646,782 | +0.3% |
| 2021-05-17 23:02 | 2021-05-13 | Pitchford William D | Officer - Chief HR Officer | BUY | $23.72 | 1,500 | $35,580 | 41,921 | +3.7% |
| 2021-05-17 23:01 | 2021-05-13 | Beattie John Gregory | Officer - Chief Operating Officer | BUY | $22.91 | 5,000 | $114,550 | 30,440 | +19.7% |
How to Interpret $NOTV Trades
Not every insider transaction in Inotiv, Inc. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $NOTV shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for NOTV
Insider activity data for Inotiv, Inc. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $NOTV, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.